Partner Content Partner Content PRISYM ID joins Siemens Digital Industries Software Solution PRISYM ID is partnering with Siemens
Views & Analysis Disrupting healthcare: 4 lessons from emerging markets Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
